Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.96 |
High Similarity |
NPD9133 |
Approved |
0.9231 |
High Similarity |
NPD9183 |
Clinical (unspecified phase) |
0.9141 |
High Similarity |
NPD9628 |
Approved |
0.8939 |
High Similarity |
NPD1451 |
Approved |
0.888 |
High Similarity |
NPD300 |
Approved |
0.8667 |
High Similarity |
NPD9627 |
Approved |
0.8647 |
High Similarity |
NPD875 |
Clinical (unspecified phase) |
0.8125 |
Intermediate Similarity |
NPD2180 |
Approved |
0.8056 |
Intermediate Similarity |
NPD1731 |
Clinical (unspecified phase) |
0.8014 |
Intermediate Similarity |
NPD2604 |
Approved |
0.8014 |
Intermediate Similarity |
NPD3697 |
Discontinued |
0.7801 |
Intermediate Similarity |
NPD5342 |
Clinical (unspecified phase) |
0.78 |
Intermediate Similarity |
NPD3130 |
Discontinued |
0.7656 |
Intermediate Similarity |
NPD9132 |
Discontinued |
0.7623 |
Intermediate Similarity |
NPD8862 |
Approved |
0.7623 |
Intermediate Similarity |
NPD8859 |
Approved |
0.7623 |
Intermediate Similarity |
NPD8861 |
Approved |
0.7468 |
Intermediate Similarity |
NPD3108 |
Clinical (unspecified phase) |
0.7431 |
Intermediate Similarity |
NPD568 |
Approved |
0.7431 |
Intermediate Similarity |
NPD567 |
Approved |
0.7431 |
Intermediate Similarity |
NPD566 |
Approved |
0.7342 |
Intermediate Similarity |
NPD3105 |
Discontinued |
0.731 |
Intermediate Similarity |
NPD3706 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD5768 |
Phase 2 |
0.7206 |
Intermediate Similarity |
NPD1389 |
Clinical (unspecified phase) |
0.7206 |
Intermediate Similarity |
NPD1388 |
Phase 1 |
0.7206 |
Intermediate Similarity |
NPD1390 |
Phase 1 |
0.7194 |
Intermediate Similarity |
NPD9081 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD1807 |
Clinical (unspecified phase) |
0.6712 |
Remote Similarity |
NPD576 |
Discontinued |
0.6364 |
Remote Similarity |
NPD7465 |
Suspended |
0.6364 |
Remote Similarity |
NPD8261 |
Discontinued |
0.6339 |
Remote Similarity |
NPD3497 |
Clinical (unspecified phase) |
0.6313 |
Remote Similarity |
NPD8641 |
Approved |
0.6272 |
Remote Similarity |
NPD1037 |
Clinical (unspecified phase) |
0.6266 |
Remote Similarity |
NPD3708 |
Phase 2 |
0.6209 |
Remote Similarity |
NPD1249 |
Clinical (unspecified phase) |
0.6145 |
Remote Similarity |
NPD459 |
Clinical (unspecified phase) |
0.6133 |
Remote Similarity |
NPD209 |
Clinical (unspecified phase) |
0.6129 |
Remote Similarity |
NPD1117 |
Clinical (unspecified phase) |
0.6118 |
Remote Similarity |
NPD3347 |
Clinical (unspecified phase) |
0.6098 |
Remote Similarity |
NPD276 |
Clinical (unspecified phase) |
0.6078 |
Remote Similarity |
NPD1808 |
Phase 1 |
0.6061 |
Remote Similarity |
NPD1335 |
Approved |
0.6056 |
Remote Similarity |
NPD9360 |
Approved |
0.6049 |
Remote Similarity |
NPD1027 |
Approved |
0.6049 |
Remote Similarity |
NPD1029 |
Clinical (unspecified phase) |
0.6049 |
Remote Similarity |
NPD1030 |
Approved |
0.6045 |
Remote Similarity |
NPD8837 |
Clinical (unspecified phase) |
0.6044 |
Remote Similarity |
NPD8113 |
Phase 2 |
0.6026 |
Remote Similarity |
NPD582 |
Approved |
0.6 |
Remote Similarity |
NPD8271 |
Discontinued |
0.5988 |
Remote Similarity |
NPD536 |
Clinical (unspecified phase) |
0.5976 |
Remote Similarity |
NPD695 |
Discontinued |
0.5976 |
Remote Similarity |
NPD1303 |
Phase 1 |
0.595 |
Remote Similarity |
NPD8185 |
Discontinued |
0.595 |
Remote Similarity |
NPD8186 |
Phase 1 |
0.5948 |
Remote Similarity |
NPD1121 |
Approved |
0.5948 |
Remote Similarity |
NPD1120 |
Approved |
0.5946 |
Remote Similarity |
NPD515 |
Phase 1 |
0.5926 |
Remote Similarity |
NPD7842 |
Phase 2 |
0.5926 |
Remote Similarity |
NPD340 |
Approved |
0.5926 |
Remote Similarity |
NPD341 |
Approved |
0.5906 |
Remote Similarity |
NPD870 |
Clinical (unspecified phase) |
0.5904 |
Remote Similarity |
NPD1290 |
Phase 2 |
0.5902 |
Remote Similarity |
NPD460 |
Discontinued |
0.5899 |
Remote Similarity |
NPD8954 |
Approved |
0.5899 |
Remote Similarity |
NPD8955 |
Approved |
0.5897 |
Remote Similarity |
NPD1118 |
Discontinued |
0.5891 |
Remote Similarity |
NPD8292 |
Phase 2 |
0.5874 |
Remote Similarity |
NPD1368 |
Approved |
0.5866 |
Remote Similarity |
NPD7246 |
Clinical (unspecified phase) |
0.5866 |
Remote Similarity |
NPD7245 |
Approved |
0.5855 |
Remote Similarity |
NPD547 |
Clinical (unspecified phase) |
0.5855 |
Remote Similarity |
NPD545 |
Clinical (unspecified phase) |
0.5851 |
Remote Similarity |
NPD8629 |
Discontinued |
0.5845 |
Remote Similarity |
NPD757 |
Phase 3 |
0.5843 |
Remote Similarity |
NPD3405 |
Phase 3 |
0.5839 |
Remote Similarity |
NPD775 |
Approved |
0.5833 |
Remote Similarity |
NPD237 |
Clinical (unspecified phase) |
0.5801 |
Remote Similarity |
NPD2009 |
Clinical (unspecified phase) |
0.5793 |
Remote Similarity |
NPD307 |
Approved |
0.5779 |
Remote Similarity |
NPD194 |
Clinical (unspecified phase) |
0.5776 |
Remote Similarity |
NPD9724 |
Phase 1 |
0.5761 |
Remote Similarity |
NPD996 |
Phase 2 |
0.5761 |
Remote Similarity |
NPD994 |
Phase 2 |
0.5759 |
Remote Similarity |
NPD1430 |
Approved |
0.5759 |
Remote Similarity |
NPD1431 |
Approved |
0.5754 |
Remote Similarity |
NPD2137 |
Approved |
0.5754 |
Remote Similarity |
NPD2138 |
Approved |
0.5742 |
Remote Similarity |
NPD252 |
Clinical (unspecified phase) |
0.574 |
Remote Similarity |
NPD1042 |
Clinical (unspecified phase) |
0.5725 |
Remote Similarity |
NPD9210 |
Phase 2 |
0.5724 |
Remote Similarity |
NPD9632 |
Phase 3 |
0.5723 |
Remote Similarity |
NPD2618 |
Phase 1 |
0.5705 |
Remote Similarity |
NPD579 |
Clinical (unspecified phase) |
0.57 |
Remote Similarity |
NPD8119 |
Discontinued |
0.5699 |
Remote Similarity |
NPD7834 |
Approved |
0.5699 |
Remote Similarity |
NPD978 |
Clinical (unspecified phase) |
0.5699 |
Remote Similarity |
NPD8410 |
Clinical (unspecified phase) |
0.5695 |
Remote Similarity |
NPD1355 |
Clinical (unspecified phase) |
0.5695 |
Remote Similarity |
NPD1354 |
Approved |
0.5695 |
Remote Similarity |
NPD1356 |
Approved |
0.5686 |
Remote Similarity |
NPD9650 |
Phase 3 |
0.5685 |
Remote Similarity |
NPD9292 |
Approved |
0.5685 |
Remote Similarity |
NPD9289 |
Approved |
0.5685 |
Remote Similarity |
NPD9288 |
Approved |
0.5685 |
Remote Similarity |
NPD76 |
Approved |
0.5682 |
Remote Similarity |
NPD8838 |
Approved |
0.5672 |
Remote Similarity |
NPD245 |
Suspended |
0.567 |
Remote Similarity |
NPD7981 |
Discontinued |
0.5652 |
Remote Similarity |
NPD9626 |
Clinical (unspecified phase) |
0.5635 |
Remote Similarity |
NPD2457 |
Phase 2 |
0.5635 |
Remote Similarity |
NPD2456 |
Phase 2 |
0.5634 |
Remote Similarity |
NPD9375 |
Discontinued |
0.5632
|
Remote Similarity |
NPD9582 |
Phase 3 |